controversy about whether long-acting beta-agonists (salmeterol, etc) should be stopped once asthma is controlled

November 2012

You'll hear new controversy about whether long-acting beta-agonists (salmeterol, etc) should be stopped once asthma is controlled.

Many patients end up on a combo corticosteroid and long-acting beta-agonist inhaler (Advair, etc) when an inhaled steroid alone is not enough for persistent asthma.

But these combo inhalers have a black box warning to stop them as soon as possible once asthma is controlled due to safety concerns.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote